CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 121 enrolled
Drug / intervention
Conivaptan +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00435591
NCT00435591Phase 4Completed
CompareCT.gov

A Phase 4, Randomized, Parallel Group, Multi-Center Study to Assess the Safety and Efficacy of Multiple Dosing Regimens of IV Conivaptan in Subjects With Euvolemic or Hypervolemic Hyponatremia

Cumberland Pharmaceuticals·interventional·Posted Feb 15, 2007·Updated May 15, 2014

In Brief

A Phase 4 clinical trial evaluating Conivaptan and placebo for Hyponatremia and 2 related conditions. Completed, enrolled 121 participants across 18 sites in 3 countries.

Detailed Summary

The study will evaluate the effectiveness and safety of multiple dosing regimens of IV conivaptan in subjects with euvolemic or hypervolemic hyponatremia

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHyponatremia, Euvolemia, Hypervolemia
CountriesIndia, Israel, United States
Collaborators--

Timeline

Phase 4CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedFeb 15, 2007
Enrollment StartJan 1, 2007
Primary CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 19.4 years ago

Interventions

Conivaptandrug

ampoule or premix bag

placebodrug

ampoule or premix bag